Report #2897992

Received May 27, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 67 yrs
State: ID
Recovered: Unknown
Vaccinated: May 21, 2026
Onset: May 21, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	P5SR5	—

Symptoms (1)

Expired product administered

Symptom narrative

Pharmacist reports that an expired Boostrix was given to a patient this week on 21-May-26; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 67-year-old female patient who received DTPa (Reduced antigen) (Boostrix) suspension for injection in pre-filled syringe (batch number P5SR5 with expiry date 26-APR-2026) for prophylaxis. On 21-MAY-2026, the patient received Boostrix. On 21-MAY-2026, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Pharmacist reports that an expired Boostrix was given to a patient this week on 21-May-26). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.; Sender's Comments: GSK-US2026068898:Same reporter/Diffrent patient